Filed pursuant to Rule 424(b)(5)
Registration Statement No. 333-262925
Supplement dated February 15, 2024
To Prospectus
Supplement dated February 23, 2022
(To Prospectus dated February 23, 2022)
Hecla Mining Company
Up to 60,000,000 Shares of Common Stock
This supplement
amends and supplements that certain prospectus supplement, dated February 23, 2022 (the Prospectus Supplement), relating to the issuance and sale from time to time of up to 60,000,000 shares of common stock (common
stock) of Hecla Mining Company through or to the sales agents named therein. Sales of our common stock, if any, pursuant to this supplement, the Prospectus Supplement and the accompanying prospectus, dated February 23, 2022 (the
accompanying prospectus), will be made in sales deemed to be at the market offerings as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended. This supplement should be read in conjunction with the Prospectus
Supplement and the accompanying prospectus. Except as set forth herein, the Prospectus Supplement remains unchanged.
This supplement is
being filed to reflect that, on February 15, 2024, we amended our equity distribution agreement, dated February 18, 2021 (the Equity Distribution Agreement and, as so amended, the Amended Equity Distribution
Agreement), with BMO Capital Markets Corp., Scotia Capital (USA) Inc., BofA Securities, Inc., B. Riley Securities, Inc., Canaccord Genuity LLC, Cantor Fitzgerald & Co Inc., CIBC World Markets Corp., Credit Suisse Securities (USA) LLC,
Goldman Sachs & Co. LLC, H.C. Wainwright & Co., LLC, J.P. Morgan Securities LLC, RBC Capital Markets, LLC and Roth Capital Partners, LLC (each, an agent and collectively, the agents), in order to
(i) add UBS Securities LLC as an agent and (ii) remove Credit Suisse Securities (USA) LLC as an agent. Accordingly, each reference to the terms sales agent and sales agents in the Prospectus Supplement is hereby
amended to (i) include UBS Securities LLC and (ii) exclude Credit Suisse Securities (USA) LLC, and each reference to equity distribution agreement in the Prospectus Supplement is hereby amended to refer to the Amended Equity
Distribution Agreement.
As of the date of this supplement, we have sold 14,505,397 shares of our common stock under the Equity
Distribution Agreement and the Prospectus Supplement and the accompanying prospectus for gross proceeds of approximately $74.0 million, net of commissions and fees of approximately $1.2 million, leaving 45,494,603 shares of our common
stock available for issuance and sale from time to time under the Amended Equity Distribution Agreement and this supplement, the Prospectus Supplement and the accompanying prospectus.
Our common stock is listed on the New York Stock Exchange (the NYSE) under the symbol HL. On February 14, 2024,
the last reported sale price of our common stock on the NYSE was $3.44 per share. Sales of common stock under this supplement, the Prospectus Supplement and the accompanying prospectus, if any, will be made by means of ordinary brokers
transactions through the facilities of the NYSE at market prices, in block transactions, or as otherwise agreed between us and any sales agent.
Investing in our common stock involves risks. See Risk
Factors on page S-3 of the Prospectus Supplement, page 7 of the accompanying prospectus and in the documents incorporated by reference in this supplement.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this supplement, the
Prospectus Supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
BMO Capital
Markets
Scotiabank
|
|
|
|
|
|
|
BofA Securities |
|
B. Riley Securities |
|
Canaccord Genuity |
|
Cantor |
CIBC Capital Markets |
|
Goldman Sachs & Co. LLC |
|
H.C. Wainwright & Co. |
|
J.P. Morgan |
RBC Capital Markets |
|
Roth Capital Partners |
|
UBS Investment Bank |
The date of this supplement is February 15, 2024.